Edwards Lifesciences has further to run
EW recently had a nice earnings beat and guidance raise. It is showing strong momentum and has broken out of a multi-year pattern. I bought a couple weeks ago, it may be vulnerable to some consolidation shortly but I think it will finish the year strongly. My target is $160 with a stop at $114.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。